<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-051875</identifier>
<setSpec>0001-6519</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Second primary tumors in head and neck cancer</dc:title>
<dc:description xml:lang="en">Introduction: The development of second primary        tumors (SPT) in patients with head and neck squamous        cell carcinoma (HNSCC) has become an increasingly        important factor in clinical treatment decisions.        Purpose: To define favourable clinical characteristics for        overall survival, in patients with SP head and neck cancer.        Material and method: Records of 633 patients with        SCC treated from 1984 to 2004 were reviewed to describe        clinical characteristics of the SPT. Results: The overall incidence        of SPT was 11%. The incidence of the index tumors        was as follows: supraglottic cancer 21% and oral cancer 16%. The most common SPT occurred in head        and neck area in 47%, lung in 32% and esophagus in        11%. Second primary was associated with a poor 5 years        survival in patients with HN-SCC (23 versus 53% in control        group). Conclusion: Because of the high rate of second        primary tumors, protocols including chemoprophylaxis        should be investigated. Prevention and early        detection are indicated</dc:description>
<dc:creator>Llorente Pendás, JL</dc:creator>
<dc:creator>Suárez Nieto, C</dc:creator>
<dc:creator>Franco Gutiérrez, V </dc:creator>
<dc:creator>Hermsen, MAJA</dc:creator>
<dc:creator>Álvarez Marcos, CA</dc:creator>
<dc:creator>Cuesta Albalad, MP</dc:creator>
<dc:creator>Fernández Espina, H</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: El desarrollo de un segundo tumor        primario (STP) en el cáncer escamoso de cabeza y        cuello (CECC) presenta elevada mortalidad y condiciona        la decisión terapéutica. Objetivo: Describir las características        clínicas de los STP y determinar su implicación en la        supervivencia. Material y método: Revisión de 633 pacientes        con CECC entre 1984-2004 describiendo las principales        características de los STP. Resultados: Se observan en el        11% de los CECC. Los tumores índice que se asocian más        a un STP son los de laringe supraglótica (21%) y cavidad        oral (16%). Los STP ocurren sobre todo en el área de cabeza        y cuello (47%), pulmón (32%) y esófago (11%). Tienen        gran impacto en la supervivencia de los pacientes        con CECC, reduciéndola en un 30% (23% versus 53% en el        grupo control). Conclusiones: Debido a la alta incidencia        de STP es necesario profundizar en su estudio para realizar        una prevención adecuada y un tratamiento eficaz</dc:description>
<dc:source>Acta Otorrinolaringol Esp;57(10): 462-466, dic. 2006. ilus, tab</dc:source>
<dc:identifier>ibc-051875</dc:identifier>
<dc:title xml:lang="es">Segundos tumores primarios en el cáncer escamoso de cabeza y cuello</dc:title>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d6409^s22080</dc:subject>
<dc:subject>^d2337^s22080</dc:subject>
<dc:subject>^d28604</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28584</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d28583</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d6409^s22047</dc:subject>
<dc:subject>^d29936^s22080</dc:subject>
<dc:subject>^d29936^s22047</dc:subject>
<dc:subject>^d2337^s22047</dc:subject>
<dc:type>article</dc:type>
<dc:date>200612</dc:date>
</metadata>
</record>
</ibecs-document>
